Dr. Thomas Devlin MD, PhD, an internationally renowned neurologist at the CHI Memorial Neuroscience Institute, will present the results from LT3001 Phase 2 trials at the ISC 2026, marking a strategic milestone in stroke care. The ISC (International Stroke Conference) will be held at the Ernest N. Morial Convention Center from February 4th to 6th in New Orleans, Louisiana.

Title: LT3001 Improves Functional Outcomes in Disabling Acute Ischemic Stroke: Results from Two Phase 2 Trials.
Date: Fri, Feb 06, 2026
Time: 12:21–12:33 pm (US Central Time)
Location: Hall D, Main Event Hall, Ernest N. Morial Convention Center
ISC information: https://eppro02.ativ.me/web/index.php?page=Session&project=ISC26&id=531898